Precision medicine platforms to guide patient management in gastrointestinal cancers: Promise and pitfalls

Programme stream(s): Treatment
Programme session type(s): Parallel session

Chair: Naureen Starling, Royal Marsden NHS Foundation Trust
Speaker: Russell Petty, University of Dundee
Speaker: Janet Graham, Beatson West of Scotland Cancer Center
Speaker: Ian Tannock, Princess Margaret Cancer Centre and University of Toronto, Canada

5:05 pm-6:35 pm

Room: Hall 1

Learning objectives:
1.To understand the evolving molecular landscape and segmentation of oesophageal adenocarcinoma and how to translate this information and other emerging data to patient benefit for precision medicine with a focus on the Oelixir Programme

2.To understand how precision medicine research programmes have been approached in other gastrointestinal cancers. What are the benefits and what has worked well? What have been the challenges? How do we engage industry? What can we learn from these programmes as we embark on a precision medicine programmed for the UK in oesophago-gastric cancer

3.A wider context for precision medicine: A perspective of precision medicine from another healthcare system (focused on GI cancers). What works and again what are the challenges. How can precision medicine be adopted in routine healthcare in the future? What are the barriers and what are the facilitators?